Alexion

Group of multinationals in Ireland has worked with academics in the pharma sector

Expert insight on hand from conference in Co Wicklow organised by Enterprise Ireland

From Monday Techstars Startup Week Dublin will host 54 events in 32 venues

Your business diary: Irish banks enter their reporting season under something of a cloud

Owner of Penneys and Primark brands to report interim results having previously anticipated first-half revenue growth in all its businesses

Letting believed to be at rent of €23 per sq ft suggests high-spec space in D15 is sparse

Irish industry’s chief looks for partnership as he admits trust is lacking

For your diary: Euro zone consumer confidence due and 2018 EY Entrepreneur Of The Year winner

European markets buoyed by speculation that US could resume trade talks with China

Results from Ryanair, Tullow Oil, Ardagh Group, Intel, Amazon and Facebook

Business This Week: results, indicators and meetings

Ryanair, Jones Lang LaSalle, Tullow Oil and Manchester United report results

Barry McCall looks at some of the standout features of Ireland’s life sciences landscape

Our young, highly educated, innovative workforce continues to draw US multinationals to Ireland

Design and construction specialist earned €10.6m profits in 2016

For Your Diary: EY Entrepreneur of the Year awards; CPL AGM; Irish retail sales

For your Diary: Ryanair, McDonald’s and the banks to reveal trading figures

Mullingar man protests against Government’s refusal to fund expensive drugs

Pharma company investigating allegations over sales practices involving Soliris

Project manager group saw pre-tax profits rise 33% last year to €12.6m

Service to northeastern US city is airline’s 12th transatlantic route

Former TD to advise clients on issues related to UK’s exit from European Union

Dizzying climb in Docklands to get a snapshot of development is a test of my courage

Mallinckrodt to base global R&D facility for medical devices in Blanchardstown

Skyline figure understates level of construction activity as sector recovers, says CIF

Project will deliver 50 jobs with workforce projected to reach 500 by 2019

French drugmaker’s advances have been rebuffed

Degos disease: Charlotte Connolly has rare condition; expensive Soliris drug sought

Report recommends financial incentives for pharmacists to supply generic drugs

‘Price-gouging like this . . . is outrageous’ she wrote as drug price rose from $13.50 to $750

Alexion Pharmaceuticals charging €4,557.50 per vial of Soliris for rare blood disorder

‘Clamour for reversal of cuts is opportunistic and not well thought through,’ says Julie O'Neill

Interview: Julie O’Neill, executive vice-president, global operations, Alexion

Biopharma group will invest €450m to expand its facility in Blanchardstown, west Dublin

Maker of ‘exorbitantly priced’ blood disorder drug declines invite to appear before TDs

Patients with rare blood diseases to get €430k drug after pressure from Government TDs

Alexion’s life-saving product Soliris is one of the most expensive drugs in the world

Minister says drugs company unable to provide Soliris at a sustainable price

Two women have the same rare condition but only one is being treated with Soliris drug